These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21159530)

  • 1. SNAP-25 may mediate the association of lead exposure and ADHD.
    Ghanizadeh A
    Eur J Paediatr Neurol; 2011 May; 15(3):280-1. PubMed ID: 21159530
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic histone modification regulates developmental lead exposure induced hyperactivity in rats.
    Luo M; Xu Y; Cai R; Tang Y; Ge MM; Liu ZH; Xu L; Hu F; Ruan DY; Wang HL
    Toxicol Lett; 2014 Feb; 225(1):78-85. PubMed ID: 24291742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNAP-25: a novel candidate gene in psychiatric genetics.
    Kovács-Nagy R; Hu J; Rónai Z; Sasvári-Székely M
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):89-94. PubMed ID: 19827316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population.
    Brophy K; Hawi Z; Kirley A; Fitzgerald M; Gill M
    Mol Psychiatry; 2002; 7(8):913-7. PubMed ID: 12232787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rodent models of attention-deficit/hyperactivity disorder.
    Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
    Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder.
    Kustanovich V; Merriman B; McGough J; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2003 Mar; 8(3):309-15. PubMed ID: 12660803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between SNAP-25 gene polymorphisms and cognition in autism: functional consequences and potential therapeutic strategies.
    Braida D; Guerini FR; Ponzoni L; Corradini I; De Astis S; Pattini L; Bolognesi E; Benfante R; Fornasari D; Chiappedi M; Ghezzo A; Clerici M; Matteoli M; Sala M
    Transl Psychiatry; 2015 Jan; 5(1):e500. PubMed ID: 25629685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder.
    Feng Y; Crosbie J; Wigg K; Pathare T; Ickowicz A; Schachar R; Tannock R; Roberts W; Malone M; Swanson J; Kennedy JL; Barr CL
    Mol Psychiatry; 2005 Nov; 10(11):998-1005, 973. PubMed ID: 16088329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsycological gender differences in healthy individuals and in pediatric neurodevelopmental disorders. A role for SNAP-25.
    Ghezzo A; Guerini FR; Bolognesi E; Matteoli M; Manca S; Sotgiu S; Bejor M; Clerici M; Chiappedi M
    Med Hypotheses; 2009 Dec; 73(6):978-80. PubMed ID: 19713048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support for the MnlI polymorphism of SNAP25; a Korean ADHD case-control study.
    Choi TK; Lee HS; Kim JW; Park TW; Song DH; Yook KW; Lee SH; Kim JI; Suh SY
    Mol Psychiatry; 2007 Mar; 12(3):224-6. PubMed ID: 17325713
    [No Abstract]   [Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment.
    Marsden CA
    Neuropharmacology; 2009 Dec; 57(7-8):577-8. PubMed ID: 19733580
    [No Abstract]   [Full Text] [Related]  

  • 13. [How does maternal alcohol consumption during pregnancy affect the development of attention deficit/hyperactivity syndrome in the child].
    Burger PH; Goecke TW; Fasching PA; Moll G; Heinrich H; Beckmann MW; Kornhuber J
    Fortschr Neurol Psychiatr; 2011 Sep; 79(9):500-6. PubMed ID: 21739408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental exposures and ADHD.
    Brondum J
    Environ Health Perspect; 2007 Aug; 115(8):A398; author reply A399. PubMed ID: 17687423
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurobiology of animal models of attention-deficit hyperactivity disorder.
    Russell VA
    J Neurosci Methods; 2007 Apr; 161(2):185-98. PubMed ID: 17275916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SNAP25 gene is linked to working memory capacity and maturation of the posterior cingulate cortex during childhood.
    Söderqvist S; McNab F; Peyrard-Janvid M; Matsson H; Humphreys K; Kere J; Klingberg T
    Biol Psychiatry; 2010 Dec; 68(12):1120-5. PubMed ID: 20950795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M; Núñez F; Ahern S; Cuffí ML; Carbonell L; Sánchez S; Fernández-Dueñas V; Ciruela F
    Neurosci Lett; 2011 Apr; 494(1):44-8. PubMed ID: 21362462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD.
    Mill J; Richards S; Knight J; Curran S; Taylor E; Asherson P
    Mol Psychiatry; 2004 Aug; 9(8):801-10. PubMed ID: 15007392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.